Closing the Evidence Gap in the Use of Emerging Testing Technologies in Clinical Practice
- 3 December 2008
- journal article
- Published by American Medical Association (AMA) in JAMA
- Vol. 300 (21) , 2542-4
- https://doi.org/10.1001/jama.2008.754
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?Genetics in Medicine, 2007
- Cost Effectiveness of Adjuvant Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast CancerJournal of Clinical Oncology, 2007
- A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/neu–Positive Breast CancerJournal of Clinical Oncology, 2007
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Insurers And ‘Targeted Biologics' For Cancer: A Conversation With Lee N. NewcomerHealth Affairs, 2007
- Influence of health insurance status on inclusion of HER-2/neu testing in the diagnostic workup of breast cancer patientsInternational Journal for Quality in Health Care, 2004
- HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness AnalysisJournal of Clinical Oncology, 2004